# Rosacea and Ivermectin

> **NCT04275999** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 30 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** ivermectin
- **BEHAVIORAL:** digital interaction
- **DEVICE:** GPSkin

## Key facts

- **NCT ID:** NCT04275999
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-16
- **Primary completion:** 2024-01-17
- **Final completion:** 2025-01-17
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04275999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04275999, "Rosacea and Ivermectin". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04275999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*